最新情報
2022/12/28
萩原悠也先生のFirst authorの論文が公表
Hagiwara Y, Nakasya A, Matsumoto T, Ikoma T, Yamamoto Y, Kurioka Y, Tsuduki T, Kajiwara T, Nishina T, Yamashita N, Moriwaki T, Hyodo I. Risk factors and efficacy outcomes of early-onset severe neutropenia due to paclitaxel or nanoparticle albumin-bound paclitaxel combined with ramucirumab in advanced gastric cancer: a multicenter retrospective cohort study.
J Gastrointest Oncol. 2022 Dec;13(6):2769-2778. doi: 10.21037/jgo-22-499.
https://jgo.amegroups.com/article/view/69742/html